DAIICHI SANKYO NORDICS APS
Global pharmaceutical company developing innovative oncology and cardiovascular medical treatments.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2018
- Founded
Key Decision Makers
Mitsuhiro Matsumoto
Outside Audit & Supervisory Board Member (Independent Auditor)
Shizuko Ueno
Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit
Yo Honma
Outside Director (Independent Director), Chairperson of the Compensation Committee
Yukiko Imazu
Outside Audit & Supervisory Board Member (Independent Auditor)
+16 more contacts in Funnelfeedr
Description
Daiichi Sankyo is a global, innovative pharmaceutical company dedicated to discovering, developing, and delivering new standards of care to improve patient lives worldwide. With a history spanning over 120 years, the company focuses on addressing high unmet medical needs, particularly in the fields...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utenlandsk enhet
- VAT Number
- Unknown
Also registered in
Decision Makers
20 contacts in FunnelfeedrMitsuhiro Matsumoto
Outside Audit & Supervisory Board Member (Independent Auditor)
Shizuko Ueno
Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit
Yo Honma
Outside Director (Independent Director), Chairperson of the Compensation Committee
Yukiko Imazu
Outside Audit & Supervisory Board Member (Independent Auditor)
Reiko Kinoshita
Outside Director (Independent Director)
Takaaki Nishii
Outside Director (Independent Director), Chairperson of the Board
Takashi Matsumoto
Director, Senior Executive Officer, Head of Global HR, CHRO
Oliver Appelhans
Head of EU Specialty Business Unit
Naoto Tsukaguchi
Head of Global Legal & IP, General Counsel (GC)
Ken Keller
Head of Oncology Business Unit
Yasuhiro Komatsu
Outside Director (Independent Director)
Tomohiro Kodama
Corporate Officer, Head of Finance & Accounting Department, Global Corporate Planning & Management
Hiroyuki Okuzawa
Representative Director, President & CEO
Terumichi Yokoyama
Audit & Supervisory Board Member
Sunao Manabe
Representative Director, Executive Chairperson
Masako Watanabe
Outside Audit & Supervisory Board Member (Independent Auditor)
Nobuo Murakami
Head of Global Corporate Strategy, Chief Strategy Officer (CStO)
Miyuki Arai
Audit & Supervisory Board Member
Joseph Kenneth Keller
Director, Head of Oncology Business Unit
Akihiro Watanabe
Outside Director (Independent Director), Chairperson of the Nomination Committee
Similar Companies
20 similar companies in Funnelfeedr
ASTRAZENECA A/S
117 employeesA global biopharmaceutical company focused on innovative, science-led medical research.
BRISTOL-MYERS SQUIBB DENMARK. FILIAL AF BRISTOL-MYERS SQUIBB AB.SVERIGE
24 employeesGlobal biopharmaceutical company developing innovative medicines for serious diseases.
ASTELLAS PHARMA A/S
65 employeesGlobal pharmaceutical company transforming innovative science into value for patients.
NOVARTIS HEALTHCARE A/S
88 employeesGlobal pharmaceutical leader developing innovative medicines to improve human health.
ABBVIE A/S
57 employeesA global biopharmaceutical company developing innovative medicines for serious diseases.
Browse More
DAIICHI SANKYO NORDICS APS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo